Market Cap

Enzymatica AB Market Capitalization:

kr648.0 Million

SEK as of Jan. 1, 2024

US$64.4 Million

business Enzymatica AB Company Profile

Enzymatica AB Main Stock Listing

OMX: ENZY

Market Capitalization History of Enzymatica AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Enzymatica AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr648.0 M -12.24%
Jan. 1, 2023 kr738.3 M -13.29%
Jan. 1, 2022 kr851.5 M -72.76%
Jan. 1, 2021 kr3.13 B 275.00%
Jan. 1, 2020 kr833.5 M 120.87%
Jan. 1, 2019 kr377.4 M -50.57%
Jan. 1, 2018 kr763.4 M 54.69%
Jan. 1, 2017 kr493.5 M -4.02%
Jan. 1, 2016 kr514.2 M -69.92%
Jan. 1, 2015 kr1.71 B -35.87%
Jan. 1, 2014 kr2.67 B -10.68%
Jan. 1, 2013 kr2.98 B 202.94%
Jan. 1, 2012 kr984.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Enzymatica AB Categories

Sweden languages Healthcare languages Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

Stocks & Indices

Enzymatica AB has the following listings and related stock indices.


Stock: OMX: ENZY

Stock: FSX: EN9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.